RecruitingNCT07213167

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

Clinical Evaluation of Low Contrast Defocus Curves, Low Light Photic Phenomena, and Dysphotopsia Profiles in Pseudophakic Patients


Sponsor

Dr. Daniel H. Chang, MD

Enrollment

120 participants

Start Date

Sep 24, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery. Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction. Participants will: * Complete two different questionnaires about their current vision * Undergo visual testing using several different devices


Eligibility

Min Age: 22 Years

Inclusion Criteria5

  • Minimum 22 years of age
  • Bilateral pseudophakia, at least 3 months postoperative from IOL implantation, with one of the study IOL models in at least one eye.
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
  • Ability to understand and respond to a questionnaire in English

Exclusion Criteria6

  • Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils.
  • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
  • Uncorrected distance visual acuity worse than 20/25 in either eye
  • Prior corneal refractive surgery (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery. Note: Prophylactic peripheral iridotomies and peripheral laser retinal repairs that, in the opinion of the investigator will not confound study outcomes are acceptable.
  • Posterior capsular opacification with grading worse than 1+
  • Ocular findings that may, in the opinion of the investigator, affect vision and/or contrast sensitivity

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNone-placebo

No interventions.


Locations(1)

Empire Eye and Laser Center

Bakersfield, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07213167


Related Trials